Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2021, Vol. 48 Issue (2): 347-352    DOI: 10.31083/j.ceog.2021.02.2358
Original Research Previous articles | Next articles
Comparison of sexual function scale scores in women according to the contraception method used as part of family planning strategy in Turkey
Banuhan Şahin1, *(), Görker Sel2, Buğra Şahin3, Şafak Hatırnaz4
1Gynecology and Obstetrics Department, Amasya University Sabuncuoglu Serefeddin Training and Research Hospital, 05000 Amasya, Turkey
2Gynecology and Obstetrics Department, Faculty of Medicine, Zonguldak Bülent Ecevit University, 267000 Zonguldak, Turkey
3Gynecology and Obstetrics Department, Turhal State Hospital, 60300 Tokat, Turkey
4Department of Gynecology and Obstetrics, IVF Unit, Medicana International Hospital, 34520 Samsun, Turkey
Download:  PDF(251KB)  ( 323 ) Full text   ( 12 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Background: Continuation of sexuality is essential for a healthy partnership. However, the contraceptive method used by women of reproductive age may affect their sexual function. Aim: This study was aimed to compare sexual function scale scores in women according to the contraception method used as part of family planning strategy in Turkey. Methods: We surveyed sexually active women who used any contraceptive method served as family planning services in Turkey (ethinylestradiol/levonorgestrel pills, copper intrauterine device, condoms) and also tubal sterilisation, or coitus interruptus. Women completed an online questionnaire which asked for information on sociodemographic factors and sexual intercourse characteristics, including items from the Female Sexual Function Index (FSFI). A total FSFI score less than 26.55 was considered to indicate sexual dysfunction. Results: The questionnaire was completed by 242 women between the ages of 18 and 40 years. Condoms (34.7%) were the most frequent and tubal sterilisation (8.3%) was the least frequent contraception method among the women. The lowest total FSFI domain score was observed in the coitus interruptus group (24.31 ± 6.92), and scores for arousal, lubrication, orgasm, and pain subgroups were at the lowest levels in this group. Female sexual dysfunction (FSD) was mostly seen in women whose partner used the coitus interruptus method (P = 0.038). Conclusion: Women who used coitus interruptus had the highest rates of sexual dysfunction compared to all other women. The prevalence of FSD was very high in this traditional contraception method group, which may be attributed to the fear of getting pregnant. We conclude that counselling on modern contraception methods as part of family planning strategy in Turkey is an excellent way to enhance female sexuality.
Key words:  Contraception      Female sexual dysfunction      Female sexual function index      Sexuality     
Submitted:  12 November 2020      Revised:  23 December 2020      Accepted:  31 December 2020      Published:  15 April 2021     
*Corresponding Author(s):  Banuhan Şahin     E-mail:  banuhansahin@gmail.com

Cite this article: 

Banuhan Şahin, Görker Sel, Buğra Şahin, Şafak Hatırnaz. Comparison of sexual function scale scores in women according to the contraception method used as part of family planning strategy in Turkey. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 347-352.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2021.02.2358     OR     https://ceog.imrpress.com/EN/Y2021/V48/I2/347

[1] S. Nayak, A. Avery, J. McLeod Griffiss, C.D. Charles, K.R. Culwell. A randomized placebo-controlled pilot study of the effect and duration of Amphora, a multipurpose vaginal pH regulator, on vaginal pH[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 736-742.
[2] G. Jarząbek-Bielecka, R. Słopień, A. Słopień, M. Pisarska-Krawczyk, W. Kędzia, M. Wilczak. The impact of oral contraception with ethinyl estradiol and chlormadinone acetate on sexual function of women[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 745-746.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9 -21 .
[3] Ibrahim Sidiqi, Patrick Alexander. Current Advances in Endovascular Therapy for Infrapopliteal Artery Disease[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 36 -50 .
[4] Prakash C. Deedwania. Management of Patients With Stable Angina and Type 2 Diabetes[J]. Reviews in Cardiovascular Medicine, 2015, 16(2): 105 -113 .
[5] Peter Shalit. Management of Dyslipidemia in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 38 -46 .
[6] Sophie Mavrogeni, Fabrizio Cantini, Gerald M. Pohost. Systemic Vasculitis: An Underestimated Cause of Heart Failure—Assessment by Cardiovascular Magnetic Resonance[J]. Reviews in Cardiovascular Medicine, 2013, 14(1): 49 -55 .
[7] Jeffrey W. Moses, Stephane Carlier, Issam Moussa. Lesion Preparation Prior to Stenting[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 16 -21 .
[8] Dean J. Kereiakes. Coronary Small-Vessel Stenting in the Era of Drug Elution[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 34 -45 .
[9] M. Pakiž, L. Lukman, N. Kozar. Patients' and physicians' expectations differ significantly during the follow-up period after completion of primary treatment of gynecological or breast cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 781 -786 .
[10] T. Tomimatsu, S. Mabuchi, T. Tsuboyama, Y. Hori, S. Sekine, T. Kimura. Malignant transformation of uterine leiomyoma: suggested by clinical, imaging, histological, and genetic findings[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 879 -882 .